Appointments
Health and care technology company, Tunstall Healthcare, has announced the appointment of Emil Peters as group CEO with effect from 16 May 2022. Tunstall Group works within the health, care and housing sectors around the world to provide technology-enabled solutions to vulnerable people and improve quality of life. Peters will ‘lead Tunstall into its next [...]
Biotech company Catamaran Bio has announced the appointment of Cherry Thomas, MD, as Chief Medical Officer (CMO). Catamaran develops off-the-shelf chimeric antigen receptor (CAR)-NK cell therapies to treat cancer. Dr Thomas has extensive pharmaceutical and biotech industry experience and expertise in the clinical development of oncology therapeutics including allogeneic cell therapies. The CMO initiated a [...]
ŌURA has announced the appointment of Tom Hale as CEO and board member. ŌURA’s smart ring delivers personalised health data, insights and daily guidance to consumers. Hale has more than 30 years of experience in the consumer technology sector, most recently as president of Momentive, where he set the Enterprise growth strategy leading to the [...]
Digital health company PneumoWave today announced the appointment of Dr Gary Cooney as Mental Health Lead. Gary is responsible for the planning and execution of addiction and other mental health-related treatment studies using PneumoWave's technology platform for diagnosis and monitoring of respiratory changes. Gary is a medical doctor and consultant psychiatrist with extensive experience working [...]
Swedish startup Flow Neuroscience has appointed Erin Sivyer Lee as CEO. Flow is the creator of Europe’s first medically-approved brain stimulation headset and behavioural therapy app to treat depression at home. Lee will focus on driving global growth to make the depression treatment readily accessible to US populations and pave the way for reimbursement within [...]
Clinical stage biotechnology company Fore Biotherapeutics has appointed Matthew E. Ros as Chief Executive Officer and Director of the Board. Prior to joining Fore, Ros was Executive Vice President and Chief Strategy and Business Officer of Epizyme, Inc., a commercial-stage and publicly traded biopharmaceutical company developing novel epigenetic therapies. Ros has held leadership positions across [...]
Clinical stage biopharmaceutical company BerGenBio has announced the appointment of Cristina Oliva as Chief Medical Officer. Oliva will head up clinical development of the BerGenBio’s selective AXL inhibitor programs. The board-certified oncologist has more than 20 years of senior clinical development experience across large pharmaceutical, biotechnology and Clinical Research Organisations (CROs). Most recently, Oliva was [...]
US clinical trials platform Medable has announced the appointment of Mike Kourey to its board of directors. The enterprise software veteran and Dialpad CFO has more than 25 years’ experience in helping hyper-growth companies scale. Kourey oversaw five successful IPOs as CFO, venture partner or audit chair, including Okta, RingCentral, Aruba Networks, Riverbed and Polycom. [...]
Oxford Science Enterprises, the "science business builder" and University of Oxford partner has appointed Heather Roxborough as partner, health tech, and Wallace Wallace as associate, life sciences. Roxborough will lead the health tech investment team to identify cutting-edge science and technology from the university's world leading academics, drive investments into new spinouts and support the scale up of existing [...]
Bionical Emas, a global contract research organisation (CRO) providing services to the pharmaceutical and biotech sectors, has appointed Ian Fraser as executive vice president (EVP) clinical development. Fraser will lead the clinical development team across the global business and becomes part of the senior leadership team, reporting to COO, Tom Watson. He has extensive international experience in the [...]
